All View

Product Information
Registration Number BR-1337
Generic Name Bevacizumab
Brand Name Mvasi
Dosage Strength 400 mg/16 mL (25 mg/mL)
Dosage Form Concentrate For Solution For Infusion (IV)
Classification Prescription Drug (Rx)
Packaging 20 mL USP/EP Type I clear, colorless glass vial with light gray elastomeric stopper and blue aluminum seal with green polypropylene flip-off cap (Box of l's)
Pharmacologic Category -
Manufacturer Amgen Manufacturing Limited
Country of Origin USA
Importer Zuellig Pharma Corporation
Distributor Zuellig Pharma Corporation
Application Type Initial
Issuance Date 28 January 2021
Expiry Date 28 January 2026